Princeton, NJ, United States of America

George E Albers-Schonberg


Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 670(Granted Patents)


Company Filing History:


Years Active: 1980-1984

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of George E Albers-Schonberg

Introduction

George E Albers-Schonberg is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of microbiology and pharmacology, holding a total of 10 patents. His work primarily focuses on the development of compounds with medicinal properties, particularly in the areas of antiparasitic and hypocholesteremic treatments.

Latest Patents

One of his latest patents involves a strain of Streptomyces for producing antiparasitic compounds. This innovation describes novel compounds produced by the fermentation of a nutrient medium with the previously undescribed microorganism Streptomyces avermitilis. These compounds, generically referred to as C-076, exhibit significant parasiticidal activity and can be utilized in compositions for oral or parenteral administration to animals for the prevention and treatment of parasitic infections. Another recent patent focuses on hypocholesteremic fermentation products and their preparation process. This patent details substances isolated after cultivating a microorganism from the genus Aspergillus in a culture medium, resulting in compounds that form a class of highly active hypocholesteremic and hypolipemic medicaments.

Career Highlights

George E Albers-Schonberg is currently associated with Merck & Company, Inc., where he continues to innovate and contribute to the field of pharmaceuticals. His extensive research and development efforts have led to advancements in treatments that address significant health issues.

Collaborations

Throughout his career, Albers-Schonberg has collaborated with esteemed colleagues, including Richard L Monaghan and Alfred W Alberts. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

George E Albers-Schonberg's contributions to the field of microbiology and pharmacology are noteworthy. His patents reflect a commitment to developing effective treatments for parasitic infections and cholesterol management. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…